Ciigma Health Foundation Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 242.05%
(FY 2020)
- Ebitda -94.39%
(FY 2020)
- Net Worth 3.94%
(FY 2020)
- Total Assets 57.42%
(FY 2020)
About Ciigma Health Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manisha Takalkar and Unmesh Takalkar serve as directors at the Company.
- CIN/LLPIN
U74999MH2014NPL257471
- Company No.
257471
- Company Classification
Private Not For Profit Company
- Incorporation Date
22 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ciigma Health Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Unmesh Takalkar  | Director | 22-Aug-2014 | Current |
| Manisha Takalkar | Director | 22-Aug-2014 | Current |
Financial Performance and Corporate Structure Insights of Ciigma Health Foundation.
Ciigma Health Foundation, for the financial year ended 2020, experienced significant growth in revenue, with a 242.05% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 3.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ciigma Health Foundation?
In 2020, Ciigma Health Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ciigma Institute Of Medical Sciences Private LimitedActive 17 years 4 monthsUnmesh Takalkar is a mutual person
United Ciigma Institute Of Medical Sciences Private LimitedActive 13 years 10 monthsManisha Takalkar and Unmesh Takalkar are mutual person
- United Ciigma Hospitals Healthcare Private LimitedActive 8 years 8 months
Unmesh Takalkar is a mutual person
Genesis Ivf And Endoscopy Centre Limited Liability PartnershipActive 12 years 27 daysManisha Takalkar and Unmesh Takalkar are mutual person
- Genesis Ivf And Endoscopy Centre Private LimitedActive 5 months 10 days
Manisha Takalkar and Unmesh Takalkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ciigma Health Foundation?
Unlock and access historical data on people associated with Ciigma Health Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ciigma Health Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ciigma Health Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
